MILBORNE PORT SURGERY
GAINSBOROUGH, MILBOURNE PORT, SHERBORNE
HF004
In those patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction who are currently treated with an ACE-I or ARB, the percentage of patients who are additionally currently treated with a beta- blocker licensed for heart failure for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 12 | 18 | 66.7% | |
| HF 4 | 2011 | 15 | 22 | 68.2% | |
| HF 4 | 2012 | 24 | 29 | 82.8% | |
| HF 4 | 2013 | 23 | 33 | 69.7% | |
| HF004 | 2014 | 0 | 0 | NA% | |
| HF004 | 2015 | 1 | 1 | 100.0% | |
| HF004 | 2016 | 1 | 1 | 100.0% | |
| HF004 | 2017 | 37 | 40 | 92.5% | |
| HF004 | 2018 | 40 | 43 | 93.0% | |
| HF004 | 2019 | 46 | 50 | 92.0% | |
| HF004 | 2020 | 55 | 59 | 93.2% | |
| HF006 | 2021 | 77 | 83 | 92.8% | |
| HF006 | 2022 | 81 | 86 | 94.2% | |
| HF006 | 2023 | 98 | 101 | 97.0% |
